Sort
261,768 grants matching “gene therapy”
Mitochondrial and Metabolic Dysfunction in Age-related Neurodegeneration
$2,420,583Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2020 · AG
Mitochondrial and Metabolic Dysfunction in Age-related Neurodegeneration
$2,420,583Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2017 · AG
Mitochondrial and Metabolic Dysfunction in Age-related Neurodegeneration
$2,420,583Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2019 · AG
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
$2,420,487George J Weiner · University Of Iowa · P50 · FY2020 · CA
Retinal aging and inherited neurodegenerative diseases
$2,420,474Anand Swaroop · National Eye Institute · ZIA · FY2012 · EY
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
$2,420,381Paul M. Lieberman · Wistar Institute · P01 · FY2025 · CA
Influenza and Emerging Infectious Diseases
$2,420,158Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
SCOR in Neurobiology of Sleep and Sleep Apnea
$2,419,747Allan Ian Pack · University Of Pennsylvania · P50 · FY2007 · HL
Functional and Structural Brain Circuits Underlying Smoking
$2,419,626Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2020 · DA
HIV persistence in vivo
$2,419,534Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts
$2,419,451Flavio Vincenti · University Of California, San Francisco · U01 · FY2014 · AI
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$2,418,418Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Clinical Epidemiology and Pathogenesis of Asymptomatic HSV
$2,417,953Anna Wald · University Of Washington · P01 · FY2013 · AI
Prevention of AIDS
$2,417,438Barbara Felber · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Whole Genome Association Analysis of Hematopoietic Cell Transplant (HCT) Outcome
$2,417,140John Andrew Hansen · Fred Hutchinson Cancer Research Center · R01 · FY2012 · HL
SPORE IN PROSTATE CANCER
$2,416,793Johns Hopkins University · P50 · FY2004 · CA
Structural characterization of tau aggregation variability and maturity in isolated cell types of the brain
$2,416,521Daniel Ryland Southworth · University Of California, San Francisco · RF1 · FY2023 · NS
Extending the Phenotype of Nonsyndromic Orofacial Clefting
$2,415,868Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DE
Engineering the Next-generation of Custom Immune Cell Therapies
$2,415,750Kole T Roybal · University Of California, San Francisco · DP2 · FY2018 · CA
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$2,415,605Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$2,415,233Giorgio Trinchieri · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Brain Tumor Therapeutic Efficacy by Quantitative MR
$2,415,224University Of Michigan At Ann Arbor · P01 · FY2002 · CA
A data-driven drug delivery (4D) platform for probing and treating the chemoresistant bone marrow microenvironment
$2,415,000Michael J Mitchell · University Of Pennsylvania · DP2 · FY2018 · TR
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL
$2,414,459Jiawei Han · University Of Illinois At Urbana-Champaign · U54 · FY2016 · GM
Treatment of Infections in Immunocompromised Children
$2,414,206Thomas J Walsh · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA